VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $690,317 | -40.6% | 16,928 | -56.2% | 0.05% | -38.7% |
| Q2 2023 | $1,162,508 | -53.5% | 38,609 | -50.0% | 0.08% | -11.8% |
| Q1 2023 | $2,497,982 | +126.2% | 77,218 | +100.0% | 0.08% | +9.0% |
| Q4 2022 | $1,104,525 | +19.0% | 38,609 | +0.4% | 0.08% | +2.6% |
| Q3 2022 | $928,000 | -8.2% | 38,461 | 0.0% | 0.08% | 0.0% |
| Q2 2022 | $1,011,000 | -31.2% | 38,461 | +0.4% | 0.08% | -25.5% |
| Q1 2022 | $1,469,000 | +20.0% | 38,311 | +0.3% | 0.10% | +17.2% |
| Q4 2021 | $1,224,000 | +40.4% | 38,211 | +29.2% | 0.09% | +33.8% |
| Q3 2021 | $872,000 | -17.4% | 29,583 | -4.8% | 0.06% | -20.7% |
| Q2 2021 | $1,056,000 | +41.6% | 31,088 | +35.5% | 0.08% | +28.1% |
| Q1 2021 | $746,000 | +32.3% | 22,943 | +46.6% | 0.06% | +20.8% |
| Q4 2020 | $564,000 | 0.0% | 15,650 | +8.7% | 0.05% | -8.6% |
| Q3 2020 | $564,000 | +9.1% | 14,400 | +2.1% | 0.06% | +7.4% |
| Q2 2020 | $517,000 | +59.6% | 14,100 | 0.0% | 0.05% | +42.1% |
| Q1 2020 | $324,000 | -21.5% | 14,100 | 0.0% | 0.04% | -5.0% |
| Q4 2019 | $413,000 | +9.5% | 14,100 | 0.0% | 0.04% | +5.3% |
| Q3 2019 | $377,000 | +6.5% | 14,100 | +1.8% | 0.04% | +2.7% |
| Q2 2019 | $354,000 | +20.8% | 13,850 | +6.1% | 0.04% | +19.4% |
| Q1 2019 | $293,000 | +6.5% | 13,050 | 0.0% | 0.03% | -3.1% |
| Q4 2018 | $275,000 | +13.6% | 13,050 | 0.0% | 0.03% | +18.5% |
| Q3 2018 | $242,000 | -10.4% | 13,050 | +8.0% | 0.03% | -10.0% |
| Q2 2018 | $270,000 | +6.3% | 12,080 | +4.3% | 0.03% | +7.1% |
| Q1 2018 | $254,000 | -3.8% | 11,578 | +1.7% | 0.03% | -3.4% |
| Q4 2017 | $264,000 | +6.5% | 11,380 | +5.6% | 0.03% | 0.0% |
| Q3 2017 | $248,000 | +4.2% | 10,780 | 0.0% | 0.03% | +3.6% |
| Q2 2017 | $238,000 | -2.1% | 10,780 | 0.0% | 0.03% | -6.7% |
| Q1 2017 | $243,000 | +7.5% | 10,780 | 0.0% | 0.03% | +3.4% |
| Q4 2016 | $226,000 | -20.7% | 10,780 | 0.0% | 0.03% | -21.6% |
| Q3 2016 | $285,000 | -4.7% | 10,780 | 0.0% | 0.04% | -14.0% |
| Q2 2016 | $299,000 | – | 10,780 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |